Frequently Asked Questions

Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.

1. HCV RNA

The HCV RNA Test detects and measures the presence of Hepatitis C virus RNA in the blood, indicating an active infection and viral load.

The test is used to confirm Hepatitis C infection, assess viral load, evaluate treatment response, and check for relapse.

No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or recent health issues.

Results are usually available within 1 to 3 days after the test.

A high viral load indicates a higher quantity of Hepatitis C virus in the blood, suggesting more active infection and potentially more severe disease.

2. Who needs peripheral artery bypass surgery?

Surgery is recommended for patients with severe PAD who have not responded to medication, lifestyle changes, or other treatments.

3. Continuous renal replacement therapy

CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.

CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.

CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.

Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.

CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.